Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFcchimeric protein targeting tissue factor

hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

(2010) E Cocco et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Anti-angiogenesis agents in metastatic or recurrent cervical cancer

(2009) Bradley J. Monk et al.   GYNECOLOGIC ONCOLOGY

Metastatic HPV-related Cervical Adenocarcinomas Presenting With Thromboembolic Events (Trousseau Syndrome): Clinicopathologic Characteristics of 2 Cases

(2009) Emanuela Veras et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines

(2009) S. Bellone et al.   JOURNAL OF VIROLOGY

Venous thromboembolism in cervical cancer

(2008) Lisa Barbera et al.   LANCET ONCOLOGY